Palliative Care in Neuro-oncology: an Update.

Brain tumor Caregiver needs Neuro-oncology Palliative care Symptom management

Journal

Current neurology and neuroscience reports
ISSN: 1534-6293
Titre abrégé: Curr Neurol Neurosci Rep
Pays: United States
ID NLM: 100931790

Informations de publication

Date de publication:
Nov 2023
Historique:
accepted: 02 09 2023
medline: 27 11 2023
pubmed: 26 9 2023
entrez: 26 9 2023
Statut: ppublish

Résumé

While the benefits of palliative care for patients with cancer are well established, palliative care in neuro-oncology is still in its early stages. However, in recent years, there has been increasing attention drawn to the need for better palliative care for patients with brain tumors. There is a growing body of literature demonstrating the high symptom burden and significant supportive care and information needs of these patients and their caregivers. In the area of caregiver needs, the last 3 years has seen a more rapid growth in recognizing and characterizing these needs. However, there remains a knowledge gap regarding the optimal means of addressing these needs. In this article, we outline important recent advances in the literature on palliative care for patients with brain tumors and highlight areas in need of greater attention and investigation.

Identifiants

pubmed: 37751050
doi: 10.1007/s11910-023-01301-2
pii: 10.1007/s11910-023-01301-2
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-656

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

John Y Rhee (JY)

Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston, MA, 02114, USA. jrhee@mgh.harvard.edu.
Department of Neuro-Oncology, Dana Farber Cancer Institute, Boston, MA, USA. jrhee@mgh.harvard.edu.
Harvard Medical School, Boston, MA, USA. jrhee@mgh.harvard.edu.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA. jrhee@mgh.harvard.edu.

Sumita Strander (S)

Harvard Medical School, Boston, MA, USA.

Alyx Podgurski (A)

Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston, MA, 02114, USA.

Daniel Chiu (D)

Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston, MA, 02114, USA.
Department of Neuro-Oncology, Dana Farber Cancer Institute, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Kate Brizzi (K)

Harvard Medical School, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Deborah A Forst (DA)

Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, 55 Fruit St, Boston, MA, 02114, USA.
Harvard Medical School, Boston, MA, USA.
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH